A Pilot Study Comparing the Use of Low-target Versus Conventional Target Advagraf (Astellas)

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2016 by University of British Columbia
Sponsor:
Collaborator:
Astellas Pharma Canada, Inc.
Information provided by (Responsible Party):
University of British Columbia
ClinicalTrials.gov Identifier:
NCT01265537
First received: December 21, 2010
Last updated: June 28, 2016
Last verified: June 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)